Researcher
Ben Sprangers
- Keywords (Hasselt University):Biomedical sciences (incl. biochemistry)
- Disciplines (Hasselt University):Immunology not elsewhere classified, Kidney diseases
- Disciplines (KU Leuven):Immunology
- See also: Ben SPRANGERS (Hasselt University)
Affiliations
- Immunology & Infection (Department)
Member
From1 Jun 2022 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Jun 2022 → Today - Biomedical Research Institute (Research institute)
Member
From1 Jun 2022 → 22 Jan 2024 - Immunology & Infection (Research group)
Member
From1 Jun 2022 → 22 Jan 2024 - Molecular Immunology (Rega Institute) (Lab)
Member
From1 Jan 2019 → Today - Tracheal Transplantation (Lab)
Member
From1 Feb 2010 → 31 Dec 2018 - Nephrology and Renal Transplantation Research Group (Division)
Member
From1 Oct 2003 → 31 Jul 2007
Projects
1 - 10 of 12
- Kidney stem/progenitor cells as a potent source for kidney-targeted cell therapyFrom2 Mar 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Kidney stem/progenitor cells as a potent source for kidney-targeted cell therapyFrom1 Oct 2021 → TodayFunding: Fund Recuperation Fiscal Exemption, BOF - projects
- Developing approaches to allow the safe and effective use of checkpoint inhibitors in solid organ transplant patientsFrom1 Mar 2021 → 30 Jun 2022Funding: Foundations, funds and other with scientific goal
- Further confirmation of the therapeutic potential of Toll Like Receptor 9 (TLR9) antagonists on type 2 airway Inflammation: allergic rhinitis (AR) and chronic rhinosinusitis with nasal polyps (CRSwNP)From1 Oct 2020 → 30 Sep 2022Funding: IOF - technology validation in lab
- Focal segmental glomerulosclerosis (FSGS) in the Flemish population: overview of epidemiological characteristics and pathophysiological analysis using single-cell and single-nucleus RNA-sequencing techniques.From1 Oct 2020 → TodayFunding: FWO fellowships
- Atomic Force Microscopy Enhanced Spectroscopy to Study Strains and Seeding of Amyloids In SituFrom1 May 2020 → TodayFunding: FWO Medium Size Research Infrastructure
- Redesigning allogeneic bone marrow transplantation as immunotherapyfor solid cancersFrom24 Oct 2018 → 30 Sep 2020Funding: BOF - Other initiatives
- Redesigning allogeneic bone marrow transplantation as immunotherapy for solid cancersFrom1 Oct 2018 → 30 Sep 2023Funding: FWO fellowships
- Mass cytometry by time-of-flight: next-generation flow cytometry for multiplexed single cell analysisFrom1 May 2018 → 30 Apr 2022Funding: FWO Medium Size Research Infrastructure
- Development of a technology platform for next-generation cytometryFrom1 Jul 2016 → 30 Jun 2020Funding: FWO Large scale research infrastructure
Publications
41 - 50 of 188
- Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes(2021)
Authors: Elisa Claeys, Eva Pauwels, Stephanie Humblet-Baron, Dominique Schols, Mark Waer, Ben Sprangers, Kurt Vermeire
- Immunization with alloantibodies-covered melanoma cells induces regional antitumor effects that become systemic when combined with 5-FU treatment(2021)
Authors: Nana Dang, Mark Waer, Ben Sprangers
Pages: 151 - 162 - Data-driven derivation and validation of novel phenotypes for acute kidney transplant rejection using semi-supervised clustering(2021)
Authors: Thibaut Vaulet, Aleksandar Senev, Elisabet Van Loon, Jasper Callemeyn, Katrien De Vusser, Ben Sprangers, Dirk Kuypers, Maarten De Vos, Bart De Moor, Maarten Naesens
- Artemisinin attenuates IgM xenoantibody production via inhibition of T cell-independent marginal zone B cell proliferation(2021)
Authors: Ben Sprangers
Pages: 583 - 591 - Drug dosing in cancer patients with decreased kidney function: A practical approach(2021)
Authors: Ben Sprangers
- Determination of free light chains: assay-dependent differences in interpretation(2021)
Authors: Xavier Bossuyt, Koen Poesen, Ben Sprangers, Michel Delforge
Pages: E69 - E71 - The effect of IGL-1 preservation solution on outcome after kidney transplantation: A retrospective single-center analysis(2021)
Authors: Julie De Beule, Steffen Fieuws, Diethard Monbaliu, Maarten Naesens, Ben Sprangers, Dirk Kuypers, Jacques Pirenne, Ina Jochmans
Pages: 830 - 837 - Initiation and termination of dialysis in older patients with advanced cancer: providing guidance in a complicated situation(2021)
Authors: Ben Sprangers, Hans Wildiers
Pages: e42 - e52 - Tyrosine kinase inhibitor-induced hypertension-marker of anti-tumour treatment efficacy or cardiovascular risk factor?(2021)
Authors: Ben Sprangers
Pages: 14 - 17 - Intratumoral immunotherapy with anti-PD-1 and TLR9 agonist induces systemic antitumor immunity without accelerating rejection of cardiac allografts(2021)
Authors: Nana Dang, Mark Waer, Ben Sprangers
Pages: 60 - 72
Patents
1 - 3 of 3